Therapeutic Efficacy of High-Dose Intravenous Immunoglobulin in Mycobacterium tuberculosis Infection in Mice

Intravenous immunoglobulin (IVIg) is used to treat patients with primary antibody deficiencies and, at high doses, to treat a range of autoimmune and inflammatory disorders. With high-dose IVIg (hdIVIg), immunomodulatory mechanisms act on a range of cells, including T cells, B cells, and dendritic c...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Roy, Eleanor, Stavropoulos, Evangelos, Brennan, John, Coade, Stephen, Grigorieva, Elena, Walker, Barry, Dagg, Belinda, Tascon, Ricardo E., Lowrie, Douglas B., Colston, M. Joseph, Jolles, Stephen
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2005
Aiheet:
Microbial Immunity and Vaccines
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1231090/
https://ncbi.nlm.nih.gov/pubmed/16113331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.73.9.6101-6109.2005
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia